Recruiting
Phase 2

COMT Inhibition

Sponsor:

University of Colorado, Denver

Code:

NCT03904498

Conditions

Alcohol Use Disorder

Attention Deficit Hyperactivity Disorder

Eligibility Criteria

Sex: All

Age: 21 - 65

Healthy Volunteers: Not accepted

Interventions

Tolcapone

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-11. This information was provided to ClinicalTrials.gov by University of Colorado, Denver on 2024-11-25.